1-7 of 7
Alessandro Bressan
Close
Sort by
Journal Articles

Tagraxofusp Shows Promising Anti-Tumoral Efficacy in Preclinical in Vitro Models of Myelofibrosis, Both As a Single Agent and in Combination with Janus Kinase Inhibitors

Maria Luisa Iannitto, Diego Bisignano, Alessio Fiascarelli, Simone Talucci, Sonia Zicari, Francesco Belli, Alessandro Bressan, Christopher Brooks, Daniela Bellarosa, Monica Binaschi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6329.
https://doi.org/10.1182/blood-2023-178864
Published: 2023
Journal Articles

PIM Inhibition By SEL24/MEN1703 Combines Synergistically with Gilteritinib in FLT3-ITD Preclinical Models of Acute Myeloid Leukemia

Daniela Bellarosa, Sonia Zicari, Giuseppe Merlino, Alessio Fiascarelli, Diego Bisignano, Francesco Belli, Clelia Irrissuto, Simone Talucci, Maria Luisa Iannitto, Mario Bigioni, Alessandro Bressan, Krzysztof Brzózka, Gabriel Ghiaur, Monica Binaschi
Journal: Blood
Blood (2022) 140 (Supplement 1): 3090–3091.
https://doi.org/10.1182/blood-2022-168491
Published: 2022
Journal Articles

SEL24/MEN1703 Inhibits PIM/FLT3 Downstream Target in Acute Myeloid Leukemia (AML) Patients: Results of the Pharmacodynamics (PD) Assay and Genomic Profiling in the First-in-Human Diamond-01 Trial

Alessandro Paoli, Daniela Bellarosa, Alessandro Bressan, Francesco Bertolini, Scott R. Solomon, Pau Montesinos, Sudipto Mukherjee, Stephen A Strickland, Giovanni Marconi, Armando Santoro, Roland B. Walter, Rachel J. Cook, Maria Calbacho, Susana Vives, Salman Fazal, Farhad Ravandi, Krzysztof Brzozka, Tomasz Rzymski, Milena Mazan, Simone Baldini, Niccolò Ravenni, Monica Binaschi, Dirk Laurent, Andrea Pellacani
Journal: Blood
Blood (2021) 138 (Supplement 1): 3436.
https://doi.org/10.1182/blood-2021-150277
Published: 2021
Journal Articles

Identification of a Pharmacodynamic Biomarker for SEL24/MEN1703, a First-in-Class Dual PIM/FLT3 Kinase Inhibitor for Acute Myeloid Leukemia, and Its Implementation in the First-in-Human Study CLI24-001

Andrea Tomirotti, PhD, Giuseppe Merlino, Alessio Fiascarelli, PhD, Simone Baldini, MD, Alessia Tagliavini, Elisa Borella, Milena Mazan, PhD, Krzysztof Brzózka, PhD, Alessandro Bressan, Andrea Pellacani, PhD MD, Massimiliano Salerno, Monica Binaschi, PhD, Daniela Bellarosa
Journal: Blood
Blood (2019) 134 (Supplement_1): 5087.
https://doi.org/10.1182/blood-2019-124800
Published: 2019
Journal Articles

MEN1112/OBT357, an Anti Bst1/CD157 Humanized Antibody Inducing Acute Myelogenous Leukemia (AML) Blast Depletion in an Autologous Ex Vivo Assay: A Potential New Targeted Therapy for AML

Adriano Venditti, MD, Francesco Buccisano, Luca Maurillo, MD, Maria Ilaria Del Principe, MD, Andrea Coppola, Patrizia Palomba, Roberto Arriga, Daniela Bellarosa, Alessandro Bressan, Keith Wilson, Stefano Manzini, Angela Capriati, MD PhD, Cecilia Simonelli, MD, Monica Binaschi, Sergio Amadori, MD, Giuseppe Sconocchia
Journal: Blood
Blood (2015) 126 (23): 788.
https://doi.org/10.1182/blood.V126.23.788.788
Published: 2015
Journal Articles

Targeting and Depletion of Acute Myeloid Leukemia Blasts By MEN1112, a Novel Humanized Defucosylated Monoclonal Antibodies with Specificity for Bst1/CD157 Antigen

Adriano Venditti, Francesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, Andrea Coppola, Patrizia Palomba, Anna Aureli, Roberto Arriga, Daniela Bellarosa, Alessandro Bressan, Stefano Manzini, Cecilia Simonelli, Monica Binaschi, Sergio Amadori, Giuseppe Sconocchia
Journal: Blood
Blood (2014) 124 (21): 2235.
https://doi.org/10.1182/blood.V124.21.2235.2235
Published: 2014
Journal Articles

MEN1112, a Novel Humanized De-Fucosylated Monoclonal Antibody with High Affinity and Specificity for Bst1/CD157 Antigen and Enhanced CD16 Binding

Dee Aud, Rachel Dusek, PhD, Arnima Bisht, PhD, Sudha Swaminithan, Rahel Awdew, Michael Trang, San Lin Lou, Stefano Manzini, Alfredo Martinez Mogarra, Alessandro Bressan, Jon Terrett, PhD, Monica Binaschi
Journal: Blood
Blood (2014) 124 (21): 3607.
https://doi.org/10.1182/blood.V124.21.3607.3607
Published: 2014